When was Disruptive Pharma founded?

Disruptive Pharma was founded in 2021.

Where is Disruptive Pharma located?

Disruptive Pharma is headquartered in Uppsala, Sweden.

Who is the current CEO of Disruptive Pharma?

Peter Asberg of Disruptive Pharma.

How many employees does Disruptive Pharma have?

As of Aug 31, 2026, the latest employee count at Disruptive Pharma is 14.

Where does Disruptive Pharma rank among its competitors?

Disruptive Pharma ranks 157th amongst 235 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ChemLex, which secured $45M in Dec, 2025.

Who are the top competitors of Disruptive Pharma?

Disruptive Pharma's top competitors include Sai Life Sciences, NFIL and ChemLex. Among them, ChemLex secured the most recent funding round in December, 2025.

Disruptive Pharma - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.disruptivepharma.com/
Email ID: *****@disruptivepharma.com

Key Metrics

Founded Year

2021

Location

Uppsala, Sweden

Stage

Public

Investors

UU Invest

Ranked

157^th among 235 active competitors

Employee Count

14 as on Aug 31, 2026

Similar Companies

Sai Life Sciences & 272 more

Exit Details

Public

View Disruptive Pharma's full profile

Disruptive Pharma got listed on Aug 21, 2026.

Click here to take a look at Disruptive Pharma's IPO in detail

Disruptive Pharma is a funded company. Disruptive Pharma has 1 institutional investor.

View details of Disruptive Pharma's funding rounds and investors

Disruptive Pharma's employee count trend

Disruptive Pharma has 14 employees as of Aug 26. Here is Disruptive Pharma's employee count trend over the years:

Employee count trend for Disruptive Pharma

Uncover Disruptive Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Disruptive Pharma include Sai Life Sciences, NFIL and ChemLex. Here is the list of Top 10 competitors of Disruptive Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sai Life Sciences 1999, Hyderabad (India), Public	Provider of drug discovery, development, and manufacturing of complex small molecules	$108M	HBM Healthcare Investments, Sequoia Capital ... & 123 others	66/100
2nd	NFIL 1967, Mumbai (India), Public	CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds	-	-	50/100
3rd	ChemLex Shanghai (China), Series B	Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis	$71M	LYFE Capital, Qiming Venture Partners & 3 others	49/100
4th	IRBM 2010, Pomezia (Italy), Funding Raised	Integrated drug discovery and preclinical development service provider	-	BioVaria, Europa	48/100
5th	Medicilon 2004, Pudong (China), Funding Raised	Integrated drug discovery and preclinical development services	-	Spinnotec, Fortune Capital & 1 others	47/100
6th	Bioduro 2005, San Diego (United States), Acquired	Global CRDMO providing integrated drug discovery, development, and manufacturing services	-	BridgeWest Group	45/100
7th	Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised	Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease	-	HHS	45/100
8th	48Hour Discovery 2017, Edmonton (Canada), Funding Raised	Developer of molecular discovery platform	-	Edmonton, K-Startup Grand Challenge	44/100
9th	Alfa Chemistry 2015, Ronkonkoma (United States), Unfunded	Supplier of research chemicals, reagents, custom synthesis, and analytical services	-	-	43/100
10th	Vernalis 1999, Wokingham (United Kingdom), Acquired	Drugs for the treatment of cough, asthma, migraine and cancer.	-	Invesco Mutual Fund, Thuja Capital & 4 others	43/100
157th	Disruptive Pharma 2021, Uppsala (Sweden), Public	CRO focused on drugs discovery services	-	UU Invest	25/100